Two Sigma Investments’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
Other funds holding RCUS
Two Sigma Investments's RCUS Position: Q3 2026 in Review
Two Sigma Investments increased its Arcus Biosciences (RCUS) stake by 109% in Q3 2026, buying an estimated $19.5M and bringing the position to 1,328,002 shares worth $34.3M. The position accounts for 0.02% of the portfolio, ranked #722.
Two Sigma Investments first reported a position in RCUS in Q2 2019 and has held it in 25 quarters since. 244 funds tracked by Wall St. Rank hold RCUS as of Q3 2026.
- Two Sigma Investments held 1,328,002 shares of Arcus Biosciences worth $34.3M as of Q3 2026.
- Two Sigma Investments bought 692,598 Arcus Biosciences shares in Q3 2026, an estimated $19.5M.
- Arcus Biosciences made up 0.02% of Two Sigma Investments's portfolio in Q3 2026, its #722 holding.
- Two Sigma Investments first reported a position in Arcus Biosciences in Q2 2019 and has held it in 25 quarters since.
- 244 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2026.
Based on Two Sigma Investments's 13F filing for Q3 2026, filed 16 Nov 2026.